Press Releases
FRISCO, TX / ACCESSWIRE / June 3, 2024 / GameSquare Holdings, Inc. ("GameSquare") (NASDAQ: GAME) , announces that on May 31, 2024, GameSquare and its Frankly Media LLC subsidiary ("Frankly") sold certain non-core assets. Immergo acquired Frankly's Content Management Software ("CMS") and XPR acquired Frankly's PR distribution business. Combined Frankly's CMS and PR distribution assets generated approximately $1.6 million in annual revenue, and GameSquare sold these... (continue reading...)
At a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis or death by 62% compared to KEYTRUDA alone in these patients
The 2.5-year recurrence-free survival rate of mRNA-4157 (V940) in combination with KEYTRUDA was 74.8% as compared to 55.6% for KEYTRUDA alone, with the benefit observed across exploratory subgroups
The companies have... (continue reading...)
Company announcementfor ROCKWOOL A/SRelease no. 30 – 2024to Nasdaq Copenhagen
3 June 2024
Report on transactions of executives and related parties in ROCKWOOL A/S shares
ROCKWOOL A/S has received and hereby provides notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in ROCKWOOL A/S made by persons discharging managerial responsibilities and/or persons closely related with them.
1 Details... (continue reading...)
NORCROSS, Ga., June 3, 2024 /PRNewswire/ -- Hi-Tech Pharmaceuticals has increased its capacity on Precision Protein™, which is arguably the best protein on the market! Precision Protein™ (100% Hydrolyzed Whey Protein comes with a never-before-seen enzyme known as Embedded Enzyme Technology™ or EET™, which completely changes the way protein behaves in your body. It works by seeking out specific points in the long amino acid chains that make up the protein... (continue reading...)
CRANBROOK, BC / ACCESSWIRE / June 3, 2024 / Eagle Royalties Ltd. ("ER.CN":CSE, or "Eagle Royalties" or the "Company") is pleased to announce the appointment of Norm Jordan as Chief Financial Officer, replacing Glen J. Diduck who is retiring effective May 31st. Mr. Jordan has over 20 years' experience with public company finances and currently serves as Controller of Eagle Royalties since its inception in November, 2022. Mr. Jordan also holds the position of Controller... (continue reading...)
More Press Releases
View Older Stories-
Zedge To Report Third Fiscal Quarter 2024 Results
-
Procure Disaster Recovery Strategy ETF (NASDAQ:FIXT) Up 35% Since Launch
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
Focus Announces That Five U.S. Business Lines of Connectus Wealth Advisers Have Joined The Colony Group
-
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
-
Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024
-
Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt Securities
-
First Fully Electronic F-TIIE Swap Trade Executed on the Bloomberg SEF
-
Bridge Investment Group Announces Hiring of Alison Brown as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge Workforce and Affordable Housing Strategy
-
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
-
NorthCoast Asset Management, a Business Line of Connectus Wealth Advisers, Joins Kovitz
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
DIGITIMES Asia: Nvidia's Jensen Huang discloses next-gen Ruben platform and physical AI vision at NTU keynote
-
Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting
-
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
-
Molecular Templates, Inc. Provides Interim Update
-
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
-
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
-
Coherent Appoints Jim Anderson as Chief Executive Officer
-
Aptevo Participating in the BIO International Convention
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
-
V2X announces successful repricing and extension of Term Loan
-
Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer
-
Kelley Shaw Joins Alliant Employee Benefits, Will Service Diverse Southeast Client Base
-
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
-
InnovAge PACE Recertified as a Great Place to Work
-
TÜV Rheinland's Northeast Technology & Innovation Center receive accreditation to verify equipment to be imported into Korea and other significant accreditations
-
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
-
Grace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
-
U.S.-based Lithium Producer International Battery Metals (IBAT) Names Iris Jancik as CEO to Lead Global Commercial Expansion
-
Teako Minerals Announces Changes to the Board of Directors and Officer Roles
-
Oleg Firer Wins Judgement Against Grenada Government for Unlawful Recall
-
Argo Completes First Phase of MOU with Connective Global, Secures R&D Facility at University Putra Malaysia
-
Ready Capital to Present at Nareit’s REITweek 2024
-
MIT Sloan Management Review Research Examines Circular Business Models' Benefit to Bottom Line and Increased Sustainability Measures
-
PureCycle Provides Update on Ironton Purification Facility
-
Modular Medical Announces Addition to the Russell Microcap(R) Index
-
Gryphon Digital Mining set to join Russell Microcap(R) Index
-
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
-
Element 29 Announces New Board Nominees
-
Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Spanish Mountain Gold Ltd.
-
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
-
Aldo Mazzaferro Joins Headwall Partners
-
Millennial Potash Announces Private Placement For Proceeds Of Up To $2,000,000
-
Atlas Lithium to Co-host the Inaugural Brazil Lithium Summit
-
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survi
-
Gear Energy Ltd. Confirms Monthly Dividend for June of $0.005 per Share